Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease

L-dopa–induced dyskinesia (LID) is a frequent motor complication of Parkinson’s disease (PD), associated with a negative prognosis. Previous studies showed an association between dopamine receptor (DR) gene (DR) variants and LID, the results of which have not been confirmed. The present study is aim...

Full description

Bibliographic Details
Main Authors:	Cristoforo Comi, Marco Ferrari, Franca Marino, Luca Magistrelli, Roberto Cantello, Giulio Riboldazzi, Maria Laura Ester Bianchi, Giorgio Bono, Marco Cosentino
Format:	Article
Language:	English
Published:	MDPI AG 2017-01-01
Series:	International Journal of Molecular Sciences
Subjects:	Parkinson’s disease SNPs personalized medicine disease progression motor complications
Online Access:	http://www.mdpi.com/1422-0067/18/2/242

Similar Items

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
by: Luca Magistrelli, et al.
Published: (2021-04-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
by: Elena Contaldi, et al.
Published: (2021-01-01)

Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
by: Kathryn Lanza, et al.
Published: (2021-03-01)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
by: Luca Magistrelli, et al.
Published: (2019-05-01)

Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease
by: Andrea Guerra, et al.
Published: (2019-11-01)

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
by: Natasa Kustrimovic, et al.
Published: (2018-07-01)

Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia
by: Joanna García, et al.
Published: (2011-09-01)

Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
by: Irene Sebastianutto, et al.
Published: (2016-12-01)

In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias
by: Rosario Sánchez-Pernaute, et al.
Published: (2007-08-01)

The Impact of <i>SNCA</i> Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
by: Luca Magistrelli, et al.
Published: (2021-08-01)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
by: Eugene Huh, et al.
Published: (2019-01-01)

Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model
by: Hye-Yeon Park, et al.
Published: (2016-05-01)

Maladaptive synaptic plasticity in L-DOPA-induced dyskinesia
by: Qiang Wang, et al.
Published: (2016-12-01)

Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
by: Francesco Bez, et al.
Published: (2016-10-01)

Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
by: Maryka Quik, et al.
Published: (2013-02-01)

Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
by: C. Laloux, et al.
Published: (2017-07-01)

Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
by: Isabel Espadas, et al.
Published: (2020-07-01)

Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID)
by: Kai Yang, et al.
Published: (2021-03-01)

Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
by: Ziqing Shi, et al.
Published: (2020-11-01)

Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
by: Fabbrini A, et al.
Published: (2021-04-01)

l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
by: Barbara Picconi, et al.
Published: (2008-02-01)

Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
by: Gurdal Sahin, et al.
Published: (2014-01-01)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
by: Fabiola De Marchi, et al.
Published: (2021-02-01)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
by: Lucia Corrado, et al.
Published: (2018-03-01)

Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
by: Chiara Fiorentini, et al.
Published: (2013-06-01)

Dopamine trasporter reversal as a pathogenic mechanism for L-dopa induced dyskinesia
by: Cheng, Christina
Published: (2009)

Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia
by: Christine Konradi, et al.
Published: (2004-11-01)

Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia
by: Mathieu Bourdenx, et al.
Published: (2014-02-01)

Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
by: Naomi P. Visanji, et al.
Published: (2009-08-01)

Excessive sensitivity to uncertain visual input in L-dopa induced dyskinesias in Parkinson’s disease: further implications for cerebellar involvement
by: James eStevenson, et al.
Published: (2014-02-01)

Implication of the serotoninergic systems in Parkinson's disease and L-Dopa-induced dyskinesia
by: Riahi, Golnasim
Published: (2012)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Implication of the serotoninergic systems in Parkinson's disease and L-Dopa-induced dyskinesia
by: Riahi, Golnasim
Published: (2012)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
by: Tanuja Bordia, et al.
Published: (2016-07-01)

GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming
by: Haruo Nishijima, et al.
Published: (2020-09-01)

L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission
by: Michael eFeyder, et al.
Published: (2011-10-01)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
by: Hesna Bektaş, et al.
Published: (2014-04-01)

Cannot write session to /tmp/vufind_sessions/sess_06tmfo64nt9tndrrn7da0nvdsp